Profound Medical Corp. (PROF) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 5.26M | 5.98M | 5.29M | 2.21M | 2.62M | 5.33M | 3.83M | 2.23M | 1.44M | 2.66M | 1.73M | 1.6M |
| Revenue Growth % | 100.8% | 12.21% | 38.1% | -0.96% | 82.14% | 100.11% | 121.63% | 39.36% | -22.64% | 56.4% | -38.52% | -20.21% |
| Cost of Goods Sold | 1.48M | 1.99M | 1.36M | 593K | 768K | 1.7M | 1.39M | 811.83K | 573K | 1.35M | 668K | 552K |
| COGS % of Revenue | 28.2% | 33.23% | 25.68% | 26.82% | 29.3% | 31.88% | 36.23% | 36.36% | 39.82% | 50.77% | 38.66% | 34.46% |
| Gross Profit | 3.78M | 3.99M | 3.93M | 1.62M | 1.85M | 3.63M | 2.44M | 1.42M | 866K | 1.31M | 1.06M | 1.05M |
| Gross Margin % | 71.8% | 66.77% | 74.32% | 73.18% | 70.7% | 68.12% | 63.77% | 63.64% | 60.18% | 49.23% | 61.34% | 65.54% |
| Gross Profit Growth % | 103.94% | 9.98% | 60.96% | 13.89% | 113.97% | 176.92% | 130.4% | 35.31% | -27.54% | 73.14% | -29.59% | 13.14% |
| Operating Expenses | 11.69M | 11.36M | 12.84M | 15.42M | 13.02M | 86.1M | -9.71M | 9.26M | 8.74M | 65.55M | 7.62M | -5.39M |
| OpEx % of Revenue | 222.09% | 190.06% | 242.84% | 697.6% | 496.72% | 1616.44% | -253.6% | 414.82% | 607.57% | 2462.62% | 440.97% | -336.2% |
| Selling, General & Admin | 6.5M | 7.09M | 7.43M | 9.33M | 8.21M | 23.77M | 8.98M | 5.06M | 4.8M | 16.89M | 4.21M | 4.33M |
| SG&A % of Revenue | 123.5% | 118.59% | 140.4% | 421.8% | 313.28% | 446.32% | 234.46% | 226.51% | 333.43% | 634.49% | 243.34% | 270.35% |
| Research & Development | 5.19M | 4.27M | 5.42M | 6.1M | 4.81M | 6.74M | 5.62M | 4.2M | 3.94M | 5.32M | 3.42M | 3.15M |
| R&D % of Revenue | 98.59% | 71.47% | 102.44% | 275.8% | 183.44% | 126.45% | 146.68% | 188.31% | 274.15% | 199.8% | 197.63% | 196.94% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 1000K | -1000K | 0 | 0 | 1000K | 0 | -1000K |
| Operating Income | -7.91M | -7.37M | -8.91M | -13.81M | -11.17M | -82.47M | 12.15M | -7.84M | -7.88M | -64.24M | -6.56M | 6.44M |
| Operating Margin % | -150.29% | -123.29% | -168.52% | -624.42% | -426.02% | -1548.31% | 317.37% | -351.19% | -547.39% | -2413.39% | -379.63% | 401.75% |
| Operating Income Growth % | 29.16% | 91.06% | -173.33% | -76.09% | -41.75% | -28.38% | 285.28% | -221.82% | -15.03% | 14.4% | -157.68% | 183.46% |
| EBITDA | -7.81M | -7.26M | -8.77M | -13.66M | -11M | -81.94M | 12.38M | -7.61M | -7.63M | -63.92M | -6.27M | 6.71M |
| EBITDA Margin % | -148.42% | -121.47% | -165.74% | -618.05% | -419.8% | -1538.22% | 323.34% | -340.71% | -530.02% | -2401.2% | -363.02% | 419.04% |
| EBITDA Growth % | 29.01% | 91.14% | -170.79% | -79.65% | -44.26% | -28.19% | 297.4% | -213.31% | -15.24% | 14.59% | -153.12% | 192.99% |
| D&A (Non-Cash Add-back) | 98.61K | 109K | 147K | 141K | 163K | 537.7K | 228.54K | 233.95K | 250K | 324.62K | 287K | 277K |
| EBIT | -7.91M | -7.37M | -8.91M | -13.81M | -11.17M | -12.59M | -12.15M | -6.9M | -7.88M | -11.68M | -6.56M | -6.44M |
| Net Interest Income | 371.78K | 0 | 0 | 0 | 0 | -2.06M | -199K | 934K | 1.32M | -323.71K | 1.01M | 125.64K |
| Interest Income | 371.78K | 0 | 0 | 0 | 0 | -1.64M | 0 | 786.75K | 850.96K | 19.52K | 1.01M | 320.17K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 419.28K | 199K | -147.25K | -471.04K | 343.23K | 0 | 194.53K |
| Other Income/Expense | 979.25K | -780K | 1.06M | -1.82M | 483K | 74.46M | -24.58M | 941.8K | 1.33M | 52.46M | 1.01M | -13.76M |
| Pretax Income | -6.93M | -8.15M | -7.86M | -15.63M | -10.68M | -8.01M | -12.42M | -6.9M | -6.54M | -11.78M | -5.55M | -7.32M |
| Pretax Margin % | -131.68% | -136.34% | -148.53% | -706.97% | -407.59% | -150.39% | -324.4% | -309% | -454.83% | -442.61% | -320.95% | -456.93% |
| Income Tax | 24.65K | 26K | 121K | 64K | 41K | -342.17K | 239.36K | 19K | 40K | -303.42K | 18K | 35K |
| Effective Tax Rate % | -0.36% | -0.32% | -1.54% | -0.41% | -0.38% | 4.27% | -1.93% | -0.28% | -0.61% | 2.58% | -0.32% | -0.48% |
| Net Income | -6.96M | -8.18M | -7.98M | -15.7M | -10.72M | -7.67M | -12.66M | -6.92M | -6.58M | -11.48M | -5.56M | -7.36M |
| Net Margin % | -132.15% | -136.77% | -150.82% | -709.86% | -409.16% | -143.97% | -330.65% | -309.85% | -457.61% | -431.21% | -321.99% | -459.11% |
| Net Income Growth % | 35.14% | -6.6% | 37.01% | -126.89% | -62.86% | 33.19% | -127.59% | 5.95% | 4% | 11.02% | 19.38% | -25.1% |
| Net Income (Continuing) | -6.96M | -8.18M | -7.98M | -15.7M | -10.72M | -7.67M | -12.66M | -6.92M | -6.58M | -11.48M | -5.56M | -7.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.19 | -0.27 | -0.27 | -0.52 | -0.36 | -0.21 | -0.38 | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |
| EPS Growth % | 47.22% | -28.57% | 28.95% | -85.71% | -38.46% | 50% | -46.15% | 20% | 18.75% | 8.7% | -8.33% | -20.69% |
| EPS (Basic) | -0.19 | -0.27 | -0.27 | -0.52 | -0.36 | -0.21 | -0.38 | -0.28 | -0.26 | -0.42 | -0.26 | -0.35 |
| Diluted Shares Outstanding | 36.3M | 30.73M | 30.1M | 30.05M | 30.04M | 25.77M | 24.64M | 24.44M | 23.84M | 21.37M | 21.4M | 21.17M |
| Basic Shares Outstanding | 36.3M | 30.73M | 30.1M | 30.05M | 30.04M | 25.77M | 24.64M | 24.44M | 23.84M | 21.37M | 21.28M | 21.17M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |